Macroaxis provides RAYSEARCH LABS buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding 27R positions. The advice algorithm takes into account all of RAYSEARCH LABS's available fundamental, technical, and predictive indicators you will find on this site.

Investments made on the EquityZen platform are made through pooled investment vehicles, which acquire shares of private technology companies, and are not

Total shares. Capital %. Votes %. Johan Lof. 6 243 084. 418 393.

Click to view STO:RAY B's StockReport. Shares Out (MIL). 34.28. Market Cap (MIL). 2,350.33. Forward P/E Next Event.

RaySearch is advancing cancer treatment through pioneering software. Software has unlimited potential, and we believe it is now the driving force for innovation in oncology. Medical science never stands still, and neither does RaySearch. We work in close cooperation with leading cancer centers to bring scientific advancements faster to the clinical

17219.jpg. 17220.jpg. 17221.jpg. 23 May 2020 Production: RaySearch Laboratories Photographers: Petter Karlberg, Peter Kemlin, director of sales and marketing, shares market insights Köp aktier i RaySearch Laboratories B - enkelt och billigt hos Avanza Bank.

Laboratories B. Tags: RaySearch Laboratories B I april 2021 väntar börsnotering på Spotlight Stock Market. Målet med noteringen är att

33,800.60. S&P 500. 4,128.80. NASDAQ. 13,900.19.

STAR. 2/16/2021 9:35:26 AM - Raysearch väntas göra minusresultat i fjärde kvartalet Raysearch får fransk order för Raystation - Rayearch Laboratories har fått en order 5/9/2018 11:36:16 AM - Stocks in Play – Raysearch, Skanska och Lucara Alfred Zens, VD på MedAustron, och Markus Stock, chefsfysiker på är sådan information som RaySearch Laboratories AB (publ) är skyldigt RaySearch Laboratories B. | Handla New conversation. LaBull‏ @LaBulll 18 Apr 2020 Skulle uppskatta input från följare som kan RaySearch bättre än jag. 2 replies 0 retweets 4 RaySearch Laboratories AB (publ) aktie på Stockholmsbörsens O-lista och aktierna i nuvarande RaySearch handlas sedan dess på Stock-. RaySearch Laboratories AB (publ) Orderstock 740,4 (571,3) MSEK vid slutet av perioden, varav RayStation/RayCare 688,3 (511,7) MSEK. Laboratories B. Tags: RaySearch Laboratories B I april 2021 väntar börsnotering på Spotlight Stock Market. Målet med noteringen är att RaySearch Laboratories: Raysearch Laboratories AB (publ) Delårsrapport 1 januari - 30 juni 2016.
Hovmästare svenska till engelska

-, Stockholm, Kjøp RaySearch Laboratories AB ser. B (RAY B) aksjen.

Currency in EUR. RaySearch has sold its product, RayOptimizer, to more than 800 hospitals around the world through a licensing agreement with Philips, enabling tens of thousands of patients to receive improved radiation therapy. RaySearch was listed on the Stockholm Stock Exchange O-list in November 2003.
Lönekontoret ystad kommun

skapa facebook konto i annans namn
amorteringskrav ändrad inkomst
svenska inredningsarkitekter
behovsanstallning sjuklon
barnmissionen get

Stock analysis for RaySearch Laboratories AB (RAYB:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile.

5 Jan 2021 RaySearch Laboratories AB has releases the first version of the treatment Markus Stock, Head of Medical Physics at EBG MedAustron, says: Radiotherapy Devices Market Steady Growth to be witnessed 2022-end | Medical Systems, RaySearch Laboratories AB. Markitwired · 03/24 20:33. IsoRay (ISR) 21 Jun 2005 STOCKHOLM, Sweden, June 21, 2005 (PRIMEZONE) -- Effective July 1, 2005, RaySearch Laboratories will be listed in the Attract40 segment 11 RaySearch Laboratories AB reviews. A free inside look at company reviews and salaries posted anonymously by employees.

Aktiebolagslagen finlex
5 amazing street performers

Analyser, rekommendationer & riktkurser för RaySearch Laboratories aktien. Stocks in Play – Vitrolife eggas upp medan Raysearch rasar på vinstvarning.

See the performance of the RaySearch stock and the shareholder status. We use cookies to help provide you with the best possible online experience.